Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium
Authors:
- 1 June 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (11) , 6937-6943
Abstract
Tumor-infiltrating lymphocytes (TIL) can be used as an immunotherapeutic tool to treat cancer. Success of this therapy depends on the homing and killing capacity of in vitro-activated and -expanded TIL. Vascular adhesion protein 1 (VAP-1) is an endothelial molecule that mediates binding of lymphocytes to vessels of inflamed tissue. Here, we studied whether VAP-1 is involved in binding of TIL, lymphokine-activated killer (LAK) cells, and NK cells to vasculature of the cancer tissue. We demonstrated that VAP-1 is expressed on the endothelium of cancer vasculature. The intensity and number of positive vessels varied greatly between the individual specimens, but it did not correlate with the histological grade of the cancer. Using an in vitro adhesion assay we showed that VAP-1 mediates adhesion of TIL, LAK, and NK cells to cancer vasculature. Treatment of the tumor sections with anti-VAP-1 Abs diminished the number of adhesive cells by 60%. When binding of different effector cell types was compared, it was evident that different cancer tissues supported the adhesion of TIL to a variable extent and LAK cells were more adhesive than TIL and NK cells to tumor vasculature. These data suggest that VAP-1 is an important interplayer in the antitumor response. Thus, by up-regulating the expression of VAP-1 in tumor vasculature, it can be possible to improve the effectiveness of TIL therapy.Keywords
This publication has 23 references indexed in Scilit:
- Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.Journal of Clinical Investigation, 1997
- Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2JNCI: Journal of the National Cancer Institute, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Lymphocyte-Endothelial Cell Adhesion Molecules at the Primary Tumor Site in Human Lung and Renal Cell CarcinomasJNCI: Journal of the National Cancer Institute, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Physiological and Molecular Mechanisms of Lymphocyte HomingAnnual Review of Immunology, 1992
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityCell, 1991
- Preferential Localization of Human Adherent Lymphokine-Activated Killer Cells in Tumor MicrocirculationJNCI: Journal of the National Cancer Institute, 1991
- Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes.Journal of Cell Biology, 1988
- Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ‐specific determinants on high endothelial venulesEuropean Journal of Immunology, 1980